NMRA - Neumora Therapeutics, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 1.73

Open

$ 1.76

Bid

$ 1.70 x 102

Ask

$ 1.94 x 500

Day's Range

$ 1.73 - $ 1.80

52 Week Range

$ 0.61 - $ 17.19

Volume

198,210

Average Volume

Market Cap

280.17M

Beta (5Y Monthly)

$ 2.17

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	03-03-2025	01-01-1970	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-06-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	03-07-2024	12-31-2023	10-K
8	11-01-2023	09-30-2023	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

This Warner Bros. Discovery Analyst Is No ...
09/16/2025 14:02:18

JP Morgan Downgrades Neumora Therapeutics ...
09/16/2025 10:39:12

JP Morgan analyst Tessa Romero downgrades Neumora Therapeutics (NASDAQ:NMRA) from Neutral to Underweight.

Neumora Therapeutics Q2 EPS $(0.33) Beats ...
08/06/2025 20:51:16

Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

12 Health Care Stocks Moving In Monday's A...
07/28/2025 21:05:57

boston-beer-posts-better-than-expected-earnings-joins-scholastic-deckers-outdoor-saia-and-other-big-stocks-moving-higher-on-friday

Boston Beer Posts Better-Than-Expected Ear...
07/25/2025 14:31:45

12 Health Care Stocks Moving In Friday's I...
07/18/2025 17:06:16

Mizuho Maintains Outperform on Neumora The...
07/16/2025 12:19:13

Mizuho analyst Graig Suvannavejh maintains Neumora Therapeutics (NASDAQ:NMRA) with a Outperform and raises the price target ...

Neumora Therapeutics Begins Phase 1 Clinic...
07/09/2025 11:08:05

NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profileNo convulsions observed...

12 Health Care Stocks Moving In Monday's A...
05/19/2025 21:05:52

On May 14, Neumora Therapeutics Received N...
05/16/2025 20:45:25

-SEC Filing

Needham Reiterates Buy on Neumora Therapeu...
05/13/2025 13:44:48

Needham analyst Ami Fadia reiterates Neumora Therapeutics (NASDAQ:NMRA) with a Buy and maintains $5 price target.

Neumora Therapeutics Q1 EPS $(0.42) Misses...
05/12/2025 20:02:03

Neumora Therapeutics (NASDAQ:NMRA) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate o...

Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

Needham Reiterates Buy on Neumora Therapeu...
04/10/2025 10:15:15

Needham analyst Ami Fadia reiterates Neumora Therapeutics (NASDAQ:NMRA) with a Buy and maintains $5 price target.

B of A Securities Downgrades Neumora Thera...
04/02/2025 12:28:11

B of A Securities analyst Geoff Meacham downgrades Neumora Therapeutics (NASDAQ:NMRA) from Buy to Underperform and lowers th...

Guggenheim Downgrades Neumora Therapeutics...
03/10/2025 15:01:10

Guggenheim analyst Yatin Suneja downgrades Neumora Therapeutics (NASDAQ:NMRA) from Buy to Neutral.

Stifel Downgrades Neumora Therapeutics to ...
03/07/2025 16:38:44

Stifel analyst Paul Matteis downgrades Neumora Therapeutics (NASDAQ:NMRA) from Buy to Hold and lowers the price target from ...

johnson--johnson-stops-late-stage-depression-study-over-insufficient-efficacy

Johnson & Johnson Stops Late-Stage Depress...
03/07/2025 14:03:50

Johnson & Johnson discontinues aticaprant's Phase 3 trial but explores future options. Another depression drug Spravato...

HC Wainwright & Co. Reiterates Buy on Neum...
03/07/2025 12:44:24

HC Wainwright & Co. analyst Douglas Tsao reiterates Neumora Therapeutics (NASDAQ:NMRA) with a Buy and maintains $18 pric...